Patient statement of satisfaction with antiemetic treatment is related to quality of life

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 6, 2000, Pages 575-578

  Bosnjak, Snezana ^a   Radulovíc, Sinia ^a   Neskovi Konstantinovi, Zora ^a   Mitrovi, Labuda ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Antiemetic treatment; Breast cancer; Patient satisfaction; Quality of life

Indexed keywords

ALPRAZOLAM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUOROURACIL; METOCLOPRAMIDE; ONDANSETRON;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT SATISFACTION; PHYSICAL ACTIVITY; QUALITY OF LIFE; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NAUSEA; PATIENT SATISFACTION; QUALITY OF LIFE; VOMITING;

EID: 0034442375     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200012000-00008     Document Type: Article

References (8)

1. Methodology of trials with antiemetics
2. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist
3. Assessing quality of life in cancer patients
4. Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer
5. Methodology of antiemetic trials: Response assessment, evaluation of new agents and definition of chemotherapy emetogenicity
6. Recommendations for the use of antiemetics: Evidence based, clinical practice guidelines
7. The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy
8. Day of assessment (DA) and question time frame (TF) affect reported quality of life after moderately emetogenic chemotherapy (MEC)